US Stocks
/
BioVie Inc. Class A Share Price

BioVie Inc. Class A Share Price

NASDAQ: BIVI | Micro Cap
$1.02
-$0.31 (-23.6%) Last updated on 08 Aug, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BioVie Inc. Class A Stock Performance

Open
$1.20
Prev. Close
$1.33
Circuit Range
N/A
Day Range
$0.98 - $1.23
Year Range
$0.98 - $3.81
Volume
32,246
Average Traded
$1.02

BioVie Inc. Class A Share Price Today

As of 10 August 2026, BioVie Inc. Class A's share price is $1.02. The stock opened at $1.20, compared to its previous close of $1.33. During today's trading session, BioVie Inc. Class A's share price traded between $0.98 and $1.23, with an average price of $1.11. Over the past 52 weeks, the stock has recorded a high of $3.81 and a low of $0.98. In terms of performance, BioVie Inc. Class A's share price has declined by 26.88% over the last six months and is down 32.89% on a year-on-year basis.

BioVie Inc. Class A Share Price Chart

$0.98$1.23
L
Show Current Price
H

BioVie Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$1.51M
PE Ratio (TTM)
-0.08
Dividend Yield
N/A
EPS (TTM)
$-12.12
Revenue (TTM)
N/A
Return On Equity (TTM)
-92.27%
Profit Margin
N/A
Debt to Equity
0.12
Quarterly Earnings Growth YoY
14.67%

BioVie Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$8.07M-$4.15M-$7.11M-$2.79M-$5.09M-$6.07M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A48.54%-71.30%60.80%-82.45%-19.30%

BioVie Inc. Class A Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$130.25M-$26.08M-$50.26M-$32.12M-$17.54M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A79.97%-92.67%36.09%45.39%

About BioVie Inc. Class A

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

BioVie Inc. Class A Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.53
$1.00
-34.38%
Jul 2026
$1.95
$1.53
-20.31%
Jun 2026
$1.42
$1.92
+31.96%
May 2026
$1.71
$1.46
-11.82%
Apr 2026
$1.37
$1.65
+17.44%
Mar 2026
$1.40
$1.41
+0.72%
Feb 2026
$1.19
$1.40
+22.37%
Jan 2026
$1.18
$1.14
-1.30%
Dec 2025
$1.50
$1.16
-18.95%
Nov 2025
$1.78
$1.43
-19.03%
Oct 2025
$2.01
$1.76
-7.85%
Sep 2025
$1.64
$1.91
+25.66%

BIVI Share Price FAQs

What is BioVie Inc. Class A share price today?

chevron-up
BioVie Inc. Class A share price today is $1.02 as on August 8, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of BioVie Inc. Class A stock?

chevron-up
The 52 week high of BioVie Inc. Class A stock is $3.81, while the 52 week low is $0.98 as of 8 Aug '26.

What is BIVI's market capitalisation today?

chevron-up
BIVI market capitalisation is $1.51M as of August 10, 2026, at 9:28 am IST.

What is BIVI's net income for the last quarter?

chevron-up
BIVI's net income for the last quarter is -0.01B USD.

What is the 5 year returns of BIVI?

chevron-up
The 5 year returns of BIVI is -99.87% as on 8 Aug '26.

What is the high & low stock price of BIVI today?

chevron-up
BIVI stock price hit a high of $1.23 and low of $0.98 as of 8 Aug '26.

Can I buy BIVI shares in India?

chevron-up
Yes. You can buy BIVI in India by opening an international trading account.